Replies to post #182320 on Biotech Values

[frontiers]

in case Abbvie wishes to buy enanta

You ever wonder about why ABBV was a bidder on IDIX? They bid $19.75 pps and lost to MRK which bid $24.50.

which BPs are left to gobble up Achn I wonder

But you never wonder about which BPs are left to gobble up ENTA???

Why is that?

No, you are completely 100% WRONG ... the list of potential bidders for ACHN includes the following --
Roche
BMY
ABBV
JNJ
NVS
and many others ...

GILD will not allowed to have the HCV market to themselves ... MRK/IDIX will offer strong competition for GILD ...ABBV/ENTA will not make much of a dent in the marketplace ... ABBV needs a nuke and ACHN will soon have a proven one in 3422 ...